Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Yogurt-Derived EV-Based Hydrogel Promotes Healing and Tissue Regeneration

By HospiMedica International staff writers
Posted on 28 Jul 2025

The development of effective biomaterials for regenerative medicine has long been hampered by several challenges, particularly in creating materials that can replicate the complex biological signaling and mechanical properties of living tissues. More...

Traditional synthetic materials fall short in mimicking cellular communication, often requiring chemical additives to achieve therapeutic outcomes. A major limitation in creating extracellular vesicle (EV)-based biomaterials has been the difficulty in producing sufficient yields of EVs, which are critical for carrying biological signals like proteins and genetic material. Now, researchers have proposed a new injectable hydrogel system that uses EVs from milk to address longstanding barriers in the development of biomaterials for regenerative medicine.

This new hydrogel platform was created by researchers at Columbia Engineering (New York, NY, USA) and the University of Padova (Padua, Italy) using an unconventional approach. The platform leverages milk-derived EVs from yogurt to form injectable hydrogels where EVs serve a dual purpose: acting as bioactive cargo and also functioning as structural building blocks by crosslinking biocompatible polymers. The design space was further validated using EVs from mammalian cells and bacteria, showing the system's modularity and compatibility with diverse vesicle sources. The hydrogel incorporates EVs directly into its framework, enabling sustained release of bioactive signals, and can be locally injected into damaged tissue. The interdisciplinary collaboration combined expertise in agricultural EV sourcing with nanomaterials and polymer engineering to create a versatile, scalable biomaterial.

The hydrogel was tested in immunocompetent mice and demonstrated high biocompatibility, with no adverse reactions. Within one week, it promoted strong angiogenic activity, a vital step in tissue regeneration, and created an immune environment rich in anti-inflammatory cell types. Published in Matter, the study confirms the hydrogel's ability to mimic living tissue and facilitate healing processes. These findings suggest the material holds promise for advanced applications in wound healing and regenerative medicine, especially where current treatments lack long-term repair efficacy. The team is now investigating how the immune responses generated by the hydrogel may further guide tissue regeneration.

“Being able to design a material that closely mimics the body’s natural environment while also speed up the healing process opens a new world of possibilities for regenerative medicine,” said Artemis Margaronis, co-lead author of the study.

Related Links:
Columbia Engineering
University of Padova


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.